Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of polymyxin B in carbapenem-resistant gram-negative bacterial infection
ChiCTR2200056667Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Feb 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in Gram-negative bacterial infection, sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Plasma polymyxin B concentration and Pharmacokinetic parameters of polymyxin B. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
polymyxin B
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR2200056667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056667.